PANODYNE - The new rapid lgM-lgG combined antibody test for COVID-19 is now available to test for the detection of lgG and lgM antibodies of coronavirus from a small specimen of human serum, plasma or whole blood. The detection works with proteins to indicate if a person's immune system has responded with the COVID-19 virus to indicate infection.

The point of care test, uses a fingertip blood sample to detect the presence of antibodies produced by the body’s immune system that lasts long after the initial infection. A positive or negative result is shown within 10 to 15 minutes.

• Easy to use and read
• No specialist equipment required
• Identifies infection before symptoms
• Identifies past infections
• Results within 10 Minutes
• Accuracy of 99.6% (IgG) / 97.8% (IgM)
• Assists in the control of viral transmission
• CE Conformity MSDS

Antibody Test for IgM:

This test detects IgM antibodies. IgM is usually the first antibody produced by the immune system when a virus attacks. A positive IgM test indicates that you may have been infected and that your immune system has started responding to the virus. When IgM is detected you may still be infected, or you may have recently recovered from a COVID-19 infection.

Antibody Test for IgG:

This test detects IgG antibodies that develop in most patients within seven to 10 days after symptoms of COVID-19 begin. IgG antibodies remain in the blood after an infection has passed. These antibodies indicate that you may have had COVID-19 in the recent past and have developed antibodies that may protect you from future infection. It is unknown at this point how much protection antibodies might provide against reinfection.